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ABSTRACT
Objective: To present the results from using biological ceramics for filling bone defects resulting from post-traumatic or orthopedic 
injuries. Methods: Thirty-six patients with bone defects caused by trauma or orthopedic injury were evaluated. Nineteen patients 
were male (52.8%) and 17 were female (47.2%). Their ages ranged from 19 to 84 years, with a mean of 45.7 years and median 
of 37 years. Only patients with defects that required at least five grams of biological ceramic were included. Eighteen cases were 
classified as orthopedic: bone defects were observed in 11 cases of total hip arthroplasty; one case of primary total hip arthroplasty, 
due to coxarthrosis; five cases of femoral or tibial open wedge osteotomy; and one case of tarsal arthrodesis. There were 18 cases of 
trauma-related defects; uninfected pseudarthrosis, eight cases; recent fractures of the tibial plateau with compression of the spongy 
bone, three cases; and exposed fractures treated with external fixators, seven cases. The surgical technique consisted of curetting 
and debriding the injury until bone suitable for grafting was found. Biological ceramic was then used to fill the defect and some 
kind of fixation was applied. Results: Among the 36 patients evaluated, it was seen that 35 (97.2%) presented integration of the 
biological ceramic, while one case of open fracture treated with external fixation had poor integration of the biological ceramic. 
Conclusion: Treatment of bone defects of orthopedic or post-traumatic etiology using a phosphocalcium ceramic composed of 
hydroxyapatite was shown to be a practical, effective and safe method.
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INTRODUCTION
Grafts are very necessary for correcting bone defects, 
which may have the aim of providing support, filling 
empty spaces or speeding up the biological repair of 
deficiencies in the bone framework.
Faced with situations requiring bone replacement, 
orthopedic surgeons can use autografts (autogenous or 
autologous grafts), homografts (homogenic or allogenic 
grafts) or heterografts (xenografts or heterologous or 
alloplastic grafts).
With regard to graft classification(1), grafts are defi-
ned as autogenous when the tissue is transferred from 
one position to another, in the same individual, which 
consequently does not provoke any immune reaction af-
ter the transplantation; these grafts can consist of either 
cortical or medullary bone. Homogenous grafts consist 
of tissues grafted between individuals of the same spe-
cies with non-identical genes, which may be fresh bone 
or it may be conserved in a bone bank. These grafts are 
treated by means of freeze-drying, autoclaving, chemical 
preservation or irradiation so that they become free from 
cell activity(2). Heterografts(1) are grafts made between 
individuals of different species. The use of bovine bones 
falls into this category. In the case of alloplastic grafts, 
an inert foreign body is implanted into the tissue, such 
as calcium phosphate, hydroxyapatite and bioceramics, 
among other types.
The biology of each of these grafts varies and may 
supply one or more of the essential components of os-
teogenesis, osteoinduction and osteoconduction(3). The 
term osteogenesis denotes the cellular elements of the 
graft that survive the transplantation and are active-
ly producing new bone. Nonetheless, although some 
cells in the graft may survive the transfer, the main 
sources of cells for this phase are the osteogenic and 
osteoprogenitor cells of the host. In osteoinduction, all 
materials are capable of inducing the transformation 
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of undifferentiated mesenchymal cells into osteoblasts 
or chondroblasts, thereby increasing bone growth or 
possibly forming bone where it is not expected. This 
mechanism has been recognized as dependent on se-
veral factors, including a specific protein: bone mor-
phogenetic protein (BMP). Both cortical bone grafts 
and spongy bone grafts contain BMP in their matrix(4). 
An osteoconducting matrix acts as a framework, and 
this occurs when a type of material (frequently inor-
ganic) allows bone apposition on preexisting bone, 
thus requiring the presence of differentiated bone and 
mesenchymal cells. Osteoconductive material under 
soft tissue will not produce bone neoformation. Ide-
ally, grafts should present a characteristic known as 
osseointegration, which is the chemical capacity to 
adhere to bone surfaces, without an intermediate layer 
of fibrous tissue(5).
Autogenous spongy bone grafts are considered to 
be the gold standard because of their osteoconducti-
vity, osteoinductiveness, osteogenic potential, absen-
ce of histocompatibility differences and incapacity to 
transmit infectious diseases. This standard graft has 
its own quota of problems, such as inadequate quan-
tity (especially in children), donor site morbidity and 
potential complications such as pain, hematoma and 
infection(6,7). To surmount these problems, biological 
alternatives have been used, particularly homografts 
and heterografts. However, limitations relating to re-
ady availability, high cost, disease transmission and 
immunogenicity problems have accelerated the search 
for synthetic materials and inert biomaterials as alter-
natives. Calcium hydroxyapatite (HA) and β tricalcium 
phosphate (β-TCP), which belong to the calcium phos-
phate ceramic family, are biocompatible osteoconduc-
tive materials that offer a chemical environment and 
surface that are suitable for new bone formation(8-11). 
Their efficacy as substitutes for autologous grafts to 
fill bone defects has been proven by several clinical 
and experimental studies(12-14).
In bone reconstruction, grafts can be structural or 
non-structural. Structural grafts are used after major re-
section or segmental failures, and a graft with the struc-
tural capacity to reconstruct the bone defects is needed. 
Non-structural grafts are generally used to correct cavity 
defects: they do not have the capacity to withstand com-
pressive forces and require complementary fixation.
The aim of this study was to present the results from 
using bioceramics to fill bone defects resulting from trau-
matic lesions and in situations of orthopedic etiology.
SAMPLE AND METHODS
A prospective study was conducted in which 36 pa-
tients with bone defects of post-traumatic or orthopedic 
etiology were evaluated. The operations were conduc-
ted between May 2007 and November 2008. The mean 
duration of clinical and radiological follow-up was two 
years and the minimum was one year. All the patients 
underwent the surgical treatment using bioceramics 
at Hospital São Bento Cardioclínica, Belo Horizonte, 
Minas Gerais.
There were 19 male patients (52.8%) and 17 female 
patients (47.2%). Their ages ranged from 19 to 84 years, 
with a mean of 45.7 years and median of 37 years. Only 
patients with defects that required a minimum of five 
grams of bioceramics were included.
The bone defects were divided into two distinct 
groups: orthopedic (O) and post-traumatic (T). Eighte-
en cases were classified as orthopedic: these bone de-
fects were observed in 11 cases of revision of total hip 
arthroplasty, one case of primary total hip arthroplasty 
due to coxarthrosis, five cases of open wedge femoral or 
tibial osteotomy and one case of tarsal arthrodesis. There 
were 18 cases of post-traumatic defect: eight cases of 
uninfected pseudarthrosis, three cases of recent fractures 
of the tibial plateau with compression of spongy bone 
and seven cases of exposed fractures that were treated 
with external fixation.
The surgical technique used in the group of ortho-
pedic defects (O) consisted of curetting and debriding 
the lesion until bone that appeared suitable for grafting 
was found. Bioceramic was then used to fill the defect. 
This procedure was used during the arthroplasty revi-
sion surgery. In the cases of open wedge osteotomy, the 
wedge opening was filled with bioceramic and fixed 
with an angled plate. In the case of tarsal arthrodesis, 
after introducing the bioceramic, plaster cast immobi-
lization was used.
In the operations on the group of post-traumatic 
defects (T), for the cases of tibial plateau fractures, 
in which there was a sunken appearance after frac-
ture reduction, the bioceramic was placed as a graft 
to sustain the reduction that had been achieved and 
fill the empty space; the fractures were fixed using 
an L-shaped plate and screws. In treating the cases 
of pseudarthrosis, the deformities were corrected by 
removing the fibrosis from the focus and filling the 
bone defect with bioceramic. In general, a place and 
screw were used for fixation.
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Independent of etiology, the bone defects consisted 
of segmental and cavity types. The segmental bone de-
fects were described in radiographic examinations as 
defects in which solution of continuity of the bone had 
occurred. On the other hand, the cavity defects did not 
present solution of continuity of the bone.
The size of the segmental bone defects was assessed 
from the radiographic examinations. Since the defects 
were irregular, with poorly defined edges, the measure-
ments on the defect started with the largest dimension 
and a summed scale to the nearest 0.5 cm was used. The 
size of the bone defect was found to range from 3.5 cm 
to 1.0 cm, with a mean of 2.0 cm.
The size of the cavity defects was not measured be-
cause of the irregularities and difficulties in the volu-
metric measurements.
The bioceramic used was phosphocalcium ceramic 
composed of porous absorbable hydroxyapatite, with 
a mean grain size ≤ 10 MESH (MESH consists of the 
number of holes in a linear inch). The grain diameter 
was around 2.5 mm, found on the market under the 
name HAP-91® (JHS Laboratório Químico Ltda.).
The patients were evaluated clinically and radiolo-
gically. Cases were considered to have been resolved if 
they presented integration of the bioceramic, absence 
of pain, joint movement and functional capacity. It was 
not possible to biopsy the region treated. All the cases 
analyzed were radiographed before the operation, im-
mediately after the operation and at a later time after 
the operation (minimum of six months). The criteria for 
the final clinical and radiological assessment took two 
points into consideration:
– Deficient integration of the bioceramic; and
– Integration of the bioceramic.
RESULT
Among the 36 patients evaluated, it was observed that 
35 (97.2%) presented integration of the bioceramic and 
these cases were considered resolved. One case of an 
exposed fracture treated with external fixation presented 
deficient integration of the bioceramic, and new surgery 
involving grafting from the iliac crest was needed.
Figures 1, 2, 3 and 4 illustrate the process of bioce-
ramic integration.
DISCUSSION
In orthopedics, bone defects are becoming increasin-
gly frequent, mainly because of increasing incidence of 
high-energy accidents and arthroplasty revision. Their 
correction thus represents a challenge(15). There are se-
veral alternatives for treating these bone defects, inclu-
ding the use of autogenous or homogenous bone grafts, 
combined with research and development on bone tissue 
replacement material, which presents the main advanta-
ges of avoiding the need to undertake a second surgical 
procedure to obtain the graft and diminishing the cost 
of storage in specific bone banks.
Autogenous grafts are the reference standard because 
of their basic characteristics and their osteoconductive, 
Source: Photo from the files of Hospital São Bento Cardioclínica – BH/MG
Figure 1 – Correction of tibial deformity using bioceramic
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osteoinductive and osteogenic properties. However, they 
have limitations resulting from donor site morbidity, 
considerable risk of infection and other limiting factors 
such as pain, reabsorption, loss of volume, need for 
new intervention, greater duration of surgery, greater 
bleeding and limited quantity.
Source: Photo from the files of Hospital São Bento Cardioclínica – BH/MG
Figure 2 – Correction of femoral deformity using bioceramic.
Source: Photo from the files of Hospital São Bento Cardioclínica – BH/MG
Figure 3 – Sequela from loosening of a total hip prosthesis. It was necessary to remove the prosthesis and correct the acetabular 
bone defect with bioceramic and a spacer. Nine months later, bone formation was confirmed and a new prosthesis was inserted.
Source: Photo from the files of Hospital São Bento Cardioclínica – BH/MG
Figure 4 – Treatment of tibial pseudarthrosis using bioceramic
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Homografts and heterografts are alternatives, but they 
generate disease transmission and tissue rejection risks.
One of the alternatives that seem increasingly promi-
sing is to use alloplastic materials. These not only have 
a filling function but also have the capability of leading 
towards structuring the area for the time required, thus 
enabling the bone regeneration process. For this, these 
materials need to have certain three-dimensional archi-
tectural characteristics, with surface topography, rough-
ness and porosity, among other features, given that the 
induction process is geometry-dependent(16).
Hydroxyapatite has been an alternative for use in 
bone defect repairs for the last 20 years. Recent deve-
lopments have led to interest in the potential of porous 
hydroxyapatite as a synthetic bone graft(17). In the pre-
sent study, a totally metabolized phosphocalcium cera-
mic biomaterial known as absorbable porous hydroxya-
patite was used. The crystalline salts deposited in the 
organic matrix of the bone were mainly composed of 
calcium and phosphates, and their structure was essen-
tially that of hydroxyapatite. This material, which was 
placed next to the bone, functioned as a support for 
bone tissue regeneration. Thus, it allowed the regenera-
tion tissue to grow within its physical structure because 
of the presence of pores, thus avoiding encapsulation 
due to fibrous connective tissue and increasing the spe-
ed of tissue growth. Synthetic calcium phosphate bone 
grafts have both osseointegration and osteoconductive 
properties. Osseointegration results from formation of 
a layer of hydroxyapatite after implantation. The Ca2+ 
and PO4
2- ions needed to establish this layer are deri-
ved from the implant and the surrounding bone. The 
paths of both of these ions have been traced in serum 
and urine, without any significant rise in serum levels. 
From this, it can be concluded that they are treated 
as part of the pool of normal ions in the body. They 
have an excellent record of biocompatibility, without 
any reports of systemic toxicity(18).
The mechanical properties of hydroxyapatite do 
not make it appropriate for load-bearing applications. 
For this, fixation is required, along with a period of 
protection(16). We did not using the bioceramic as a struc-
tural graft: its density does not allow bone formation 
inside it. Containment of the bioceramic is more difficult 
in segmental bone defects, since stable fixation is needed 
until bone consolidation has been achieved. Hence, we 
used the bioceramic in small segmental defects.
All the patients with bone defects of orthopedic cause 
evolved well, without intercurrences, and bioceramic 
integration occurred. Out of the 18 patients with post-
traumatic bone defects, only one presented deficient 
integration of the bioceramic, for which a new operation 
together with grafting from the iliac crest was needed.
Hydroxyapatite combined with bone marrow aspira-
te, because of its osteogenic property, has been used in 
several studies on bone regeneration, and good results 
have been demonstrated(13,14,19).
Ceramics offer desirable characteristics such as bio-
compatibility for use as bone implants, chemical inert-
ness in biological mediums and hardness, but they have 
low resistance to traction(20). It needs to be emphasized 
that technical care is extremely importance, in order to 
avoid extravasation of the bioceramic granules, given 
that they could cause abrasion and catastrophic failure 
because of their hardness.
CONCLUSION
Treatment of bone defects of post-traumatic or ortho-
pedic etiology was shown in this study, through the use 
of phosphocalcium ceramic composed of hydroxyapa-
tite, to be a practical, effective and safe method.
REFERENCES
Costa OR, Veinstein FJ. Injertos oseos em regeneración periodontal. Rev Asoc 1. 
Odont Argent. 1994;82(2):117-25.
Fossum TW. Cirurgia de pequenos animais. São Paulo: Roca; 2002. p. 792 2. 
– 9; 848– 53.
Misch CE, Dietsh F. Bone-grafting materials in implant dentistry. Implant Dent. 3. 
1993;2(3):158-67.
Martinez SA, Walker T. Bone grafts. Vet Clin North Am Small Anim Pract. 4. 
1999;29(5):1207-19.
Costantino PD, Friedman CD. Synthetic bone graft substitutes. Otolaryngol Clin 5. 
North Am. 1994;27(5):1037-74.
Giannoudis PV, Divinopoulos H, Tsiridis E. Bones substitutes: an update. Injury. 6. 
2005;36:S20.
Finkemeier CG. Bone-grafting and bone-graft substitutes. J Bone Joint Surg 7. 
Am. 2002;84(3):454-64.
Jarcho M. Calcium phosphate ceramics as hard tissue prosthetics. Clin Orthop 8. 
Relat Res. 1981;(157):259-78.
Natarajan M, Dhanapal R, Kumaravel S, Selvaraj R, Uvaraj NR. The use of 9. 
bovine calcium hydroxyapatite in filling defects following curettage of benign 
bone tumours. Indian J Orthop. 2003;37:192-4.
Matsumine A, Myoui A, Kusuzaki K, Araki N, Seto M, Yoshikawa H, Uchida A. 10. 
Calcium hydroxyapatite ceramic implants in bone tumour surgery. A long-term 
follow-up study. J Bone Joint Surg Br. 2004;86(5):719-25.
Reddy R, Swamy MK. The use of hydroxyapatite as a bone graft substitute in 11. 
orthopaedic conditions. Indian J Orthop. 2005;39(1):52-4.
438
Rev Bras Ortop. 2010;45(4):433-8
Miranda ES, Cardoso FTS, Medeiros Filho JF, Barreto MDR, Teixeira RMM, 12. 
Wanderley AL, et al. Estudo experimental comparativo no uso de enxerto ósseo 
orgânico e inorgânico no reparo de fraturas cirúrgicas em rádio de coelhos. 
Acta Orthop Bras. 2005;13(5):245-8.
Saikia KC, Bhattacharya TD, Bhuyan SK, Talukdar DJ, Saikia SP, Jitesh P. 13. 
Calcium phosphate ceramics as bone graft substitutes in filling bone tumor 
defects. Indian J Orthop. 2008;42(2):169-72.
Bansal S, Chauhan V, Sharma S, Maheshwari R, Juyal A, Raghuvanshi S. 14. 
Evaluation of hydroxyapatite and beta-tricalcium phosphate mixed with bone 
marrow aspirate as a bone graft substitute for posterolateral spinal fusion. Indian 
J Orthop. 2009;43(3):234-9.
Oonishi H, Iwaki Y, Kin N, Kushitani S, Murata N, Wakitani S, Imoto K. Hydro-15. 
xyapatite in revision of total hip replacements with massive acetabular defects: 
4- to 10-year clinical results. J Bone Joint Surg Br. 1997;79(1):87-92.
Azevedo VVC, Chaves SA, Bezerra DC, Costa ACFM. Materiais cerâmicos 16. 
utilizados para implantes. Revista Eletrônica de Materiais e Processos. 2008; 
3(1):31-9.
Hing KA, Best SM, Bonfield W. Characterization of porous hydroxyapatite. J 17. 
Mater Sci Mater Med. 1999;10(3):135-45.
Moore WR, Graves SE, Bain GI. Synthetic bone graft substitutes. ANZ J Surg. 18. 
2001;71(6):354-61.
Zabeu JLA, Mercadante MT. Substitutos ósseos comparados ao enxerto ósseo 19. 
autólogo em cirurgia ortopédica – Revisão sistemática da literatura. Rev Bras 
Ortop. 2008; 43(3):59-68.
Olsson DC, Pippi NL, Tognoli GK, Raiser AG. Comportamento biológico de 20. 
matriz scaffold acrescida de células progenitoras na reparação óssea. Ciência 
Rural. 2008; 38(8):2403-12.
